Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study.

Journal: Journal of cachexia, sarcopenia and muscle

Volume: 7

Issue: 3

Year of Publication: 2016

Affiliated Institutions:  Parc Sanitari Sant Joan de Déu Universitat de Barcelona. Fundació Sant Joan de Déu Dr Antoni Pujades, Sant Boi de Llobregat BarcelonaSpain; Instituto de Salud Carlos III Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM Monforte de Lemos -, Pabellón Madrid Spain. Instituto de Salud Carlos III Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM Monforte de Lemos -, Pabellón Madrid Spain; Department of Psychiatry Universidad Autónoma de Madrid, Instituto de Investigación Sanitaria Princesa (IP), Hospital Universitario la Princesa Madrid Spain. Department of Health Statistics and Information Systems World Health Organization Geneva Switzerland. Department of Medical Sociology Jagiellonian University Medical College Krakow Poland. National Institute for Health and Welfare Helsinki Finland. Neurology, Public Health and Disability Unit Neurological Institute 'Carlo Besta' Foundation IRCCS (Istituto di ricovero e cura a carattere scientifico) Milan Italy.

Abstract summary 

The aim of this study was to evaluate the factors associated with low skeletal muscle mass (SMM), sarcopenia, and sarcopenic obesity using nationally representative samples of people aged ≥65 years from diverse geographical regions of the world.Data were available for 18 363 people aged ≥65 years who participated in the Collaborative Research on Ageing in Europe survey conducted in Finland, Poland, and Spain, and the World Health Organization Study on global AGEing and adult health survey conducted in China, Ghana, India, Mexico, Russia, and South Africa, between 2007 and 2012. A skeletal muscle mass index (SMI) was created to reflect SMM. SMM, SMI, and percent body fat (%BF) were calculated with specific indirect population formulas. These estimates were based on age, sex, weight, height, and race. Sarcopenia and sarcopenic obesity were defined with specific cut-offs.The prevalence of sarcopenia ranged from 12.6% (Poland) to 17.5% (India), and that of sarcopenic obesity ranged from 1.3% (India) to 11.0% (Spain). Higher %BF was associated with lower SMM in all countries, and with sarcopenia in five countries (p < 0.001). Compared to high levels of physical activity, low levels were related with higher odds for sarcopenia [OR 1.36 (95%CI 1.11-1.67)] and sarcopenic obesity [OR 1.80 (95%CI 1.23-2.64)] in the overall sample. Also, a dose-dependent association between higher numbers of chronic diseases and sarcopenic obesity was observed.Physical activity and body composition changes such as high %BF are key factors for the prevention of sarcopenia syndrome.

Authors & Co-authors:  Tyrovolas Stefanos S Koyanagi Ai A Olaya Beatriz B Ayuso-Mateos Jose Luis JL Miret Marta M Chatterji Somnath S Tobiasz-Adamczyk Beata B Koskinen Seppo S Leonardi Matilde M Haro Josep Maria JM

Study Outcome 

Source Link: Visit source

Statistics
Citations :  WHO. Active ageing. A policy framework [On‐line]. http://whqlibdoc.who.int/hq/2002/WHO_NMH_NPH_02.8.pdf Accessed 14 March 2014.
Authors :  10
Identifiers
Doi : 10.1002/jcsm.12076
SSN : 2190-5991
Study Population
Male,Female
Mesh Terms
Other Terms
Older adults;Sarcopenia;Sarcopenic obesity;Skeletal muscle mass
Study Design
Cross Sectional Study
Study Approach
Country of Study
Ghana
Publication Country
Germany